The effect of anti-gp39 treatment on the intestinal manifestations of acute murine graft-versus-host disease

Copyright 1999 Academic Press.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 90(1999), 3 vom: 01. März, Seite 334-9
1. Verfasser: Stüber, E (VerfasserIn)
Weitere Verfasser: von Freier, A, Fölsch, U R
Format: Aufsatz
Sprache:English
Veröffentlicht: 1999
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Antibodies, Monoclonal Membrane Glycoproteins CD40 Ligand 147205-72-9
Beschreibung
Zusammenfassung:Copyright 1999 Academic Press.
The changes in the intestinal morphology of murine T-cell-mediated acute semi-allogenic graft-versus-host disease (GvH) are characterized by lymphocytic infiltrates, crypt hyperplasia, and villous atrophy. In the present study, the role of CD40L (gp39)-an important member of the TNF/NGF superfamily of receptors and their ligands-for T-cell costimulation in vivo during the development of mucosal atrophy was investigated. We found that the inhibition of the CD40L-CD40 interaction in GvH animals by the administration of an anti-CD40L antibody (MR-1) completely prevents the development of crypt hyperplasia and villous atrophy in GvH animals. This includes a normalization of the rate of crypt cell apoptosis, which is augmented in untreated GvH animals. In conclusion, the CD40L-CD40 interaction is crucial in the pathogenesis of T-cell-mediated mucosal atrophy
Beschreibung:Date Completed 13.04.1999
Date Revised 15.11.2006
published: Print
Citation Status MEDLINE
ISSN:1521-6616